1. Home
  2. GKOS vs MOS Comparison

GKOS vs MOS Comparison

Compare GKOS & MOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • MOS
  • Stock Information
  • Founded
  • GKOS 1998
  • MOS 2004
  • Country
  • GKOS United States
  • MOS United States
  • Employees
  • GKOS N/A
  • MOS 14049
  • Industry
  • GKOS Medical/Dental Instruments
  • MOS Agricultural Chemicals
  • Sector
  • GKOS Health Care
  • MOS Industrials
  • Exchange
  • GKOS Nasdaq
  • MOS Nasdaq
  • Market Cap
  • GKOS 7.4B
  • MOS 8.4B
  • IPO Year
  • GKOS 2015
  • MOS 2004
  • Fundamental
  • Price
  • GKOS $138.39
  • MOS $26.44
  • Analyst Decision
  • GKOS Strong Buy
  • MOS Buy
  • Analyst Count
  • GKOS 12
  • MOS 9
  • Target Price
  • GKOS $135.08
  • MOS $32.50
  • AVG Volume (30 Days)
  • GKOS 600.5K
  • MOS 3.9M
  • Earning Date
  • GKOS 11-04-2024
  • MOS 11-12-2024
  • Dividend Yield
  • GKOS N/A
  • MOS 3.18%
  • EPS Growth
  • GKOS N/A
  • MOS N/A
  • EPS
  • GKOS N/A
  • MOS 1.15
  • Revenue
  • GKOS $360,347,000.00
  • MOS $11,456,400,000.00
  • Revenue This Year
  • GKOS $22.68
  • MOS N/A
  • Revenue Next Year
  • GKOS $24.98
  • MOS $2.78
  • P/E Ratio
  • GKOS N/A
  • MOS $22.93
  • Revenue Growth
  • GKOS 18.70
  • MOS N/A
  • 52 Week Low
  • GKOS $59.22
  • MOS $24.12
  • 52 Week High
  • GKOS $145.84
  • MOS $38.30
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 55.15
  • MOS 49.83
  • Support Level
  • GKOS $124.60
  • MOS $25.66
  • Resistance Level
  • GKOS $145.84
  • MOS $28.29
  • Average True Range (ATR)
  • GKOS 5.15
  • MOS 0.94
  • MACD
  • GKOS 0.30
  • MOS -0.13
  • Stochastic Oscillator
  • GKOS 64.92
  • MOS 39.74

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

About MOS Mosaic Company (The)

Formed in 2004 by the combination of IMC Global and Cargill's fertilizer business, Mosaic is one of the largest phosphate and potash producers in the world. The company's assets include phosphate rock mines in Florida, Brazil, and Peru and potash mines in Saskatchewan, New Mexico, and Brazil. Mosaic also runs a large fertilizer distribution operation in Brazil through its Mosaic Fertilizantes business, which the company acquired from Vale in 2018.

Share on Social Networks: